Key statistics
As of last trade, Pacira Biosciences Inc (PCRX:NSQ) traded at 14.34, 28.45% above the 52 week low of 11.16 set on Aug 13, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 14.39 |
---|---|
High | 14.59 |
Low | 13.93 |
Bid | 14.33 |
Offer | 14.34 |
Previous close | 14.53 |
Average volume | 1.58m |
---|---|
Shares outstanding | 46.13m |
Free float | 45.19m |
P/E (TTM) | 12.42 |
Market cap | 670.22m USD |
EPS (TTM) | 1.17 USD |
Data delayed at least 15 minutes, as of Sep 23 2024 19:08 BST.
More ▼
- Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
- Pacira BioSciences Comments on Ruling on EXPAREL Patent Litigation from U.S. District Court for the District of New Jersey
- Pacira BioSciences Reports Second Quarter 2024 Financial Results
- Pacira to Report Second Quarter 2024 Financial Results on Tuesday July 30, 2024
- Centers for Medicare and Medicaid Propose New Reimbursement for EXPAREL in All Outpatient Surgical Environments Beginning January 1, 2025
- Pacira BioSciences to Participate in Fireside Chat at the 2024 Jefferies Global Healthcare Conference
- Pacira BioSciences, Inc. Announces Pricing of $250.0 Million Aggregate Principal Amount of 2.125% Convertible Senior Notes due 2029
- Pacira BioSciences, Inc. Announces Proposed Offering of $250.0 Million Aggregate Principal Amount of Convertible Senior Notes
- Pacira BioSciences to Participate in Fireside Chat at the 2024 RBC Capital Markets Global Healthcare Conference
- Pacira to Report First Quarter 2024 Financial Results on Tuesday May 7, 2024
More ▼